NCT02500186View on ClinicalTrials.gov

The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Diabetes Melltius, Type 2
Interventions
DRUG

Luseogliflozin

Study patients orally receive luseogliflozin 2.5 mg s.i.d. before breakfast for 7 days from the 8th day of starting the study meal to the 14th day.

OTHER

Meal containing different carbohydrate ratio and GI value

High GI meal containing 55% carbohydrate Low GI meal containing 55% carbohydrate High GI meal containing 40% carbohydrate

All Listed Sponsors
collaborator

Medical Corporation Heishinkai OCROM Clinic

UNKNOWN

lead

Kansai Electric Power Hospital

OTHER

NCT02500186 - The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor | Biotech Hunter | Biotech Hunter